Janus kinase 3
Janus kinase 3 (JAK3) is a protein that in humans is encoded by the JAK3 gene. It is a member of the Janus kinase family and plays a critical role in the JAK-STAT signaling pathway, which is involved in the control of cell growth, cell differentiation, and immune system function. JAK3 specifically is essential for the signaling of cytokines that bind to the Type I and Type III receptor families.
Function
JAK3 is predominantly expressed in immune cells, including T cells, B cells, and natural killer cells. It is involved in the signaling pathway of cytokines such as interleukin-2, interleukin-4, interleukin-7, interleukin-9, interleukin-15, and interleukin-21, which are crucial for lymphocyte development, function, and homeostasis. Activation of JAK3 leads to the phosphorylation and activation of STATs (Signal Transducers and Activators of Transcription), which then translocate to the nucleus to effect gene expression.
Clinical Significance
Mutations in the JAK3 gene can lead to immunodeficiency syndromes, including severe combined immunodeficiency (SCID). Patients with JAK3-deficient SCID exhibit a lack of T cells and NK cells, while B cells are present but functionally impaired. This condition is characterized by a severe impairment in both cellular and humoral immunity, leading to a high susceptibility to infections.
In addition to its role in immunodeficiency, JAK3 is a target for drug discovery due to its involvement in various autoimmune diseases and cancers. Inhibitors of JAK3, such as tofacitinib, are being developed and used in the treatment of conditions like rheumatoid arthritis, psoriasis, and ulcerative colitis.
Inhibitors
Several small molecule inhibitors targeting JAK3 have been identified and are in various stages of development and clinical trials for the treatment of autoimmune diseases and cancers. These inhibitors work by blocking the kinase activity of JAK3, thereby interrupting the JAK-STAT signaling pathway and reducing the inflammatory and proliferative responses.
See Also
- Janus kinase
- JAK-STAT signaling pathway
- Signal Transducer and Activator of Transcription
- Severe combined immunodeficiency
- Tofacitinib
References
<references />
This article is a medical stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers a medical weight loss program to GLP1 weight loss doctor Philadelphia. Our physician-supervised medical weight loss NYC provides:
- Weight loss injections NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Learn more on Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $29.99 for the starting dose of Semaglutide and $45.00 for Tirzepatide with insurance for the visit.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:GLP1 medical weight loss doctor NYC, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss Wegovy NYC and Best weight loss program NYC
Error creating thumbnail: Facebook_Shiny_Icon YouTube_icon_(2011-2013)
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian